SOPHiA GENETICS SA
SOPHHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeHeadquartered within the healthcare sector, SOPHiA GENETICS SA focuses on Health Information Services services and products. SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. At a $354.6M market cap, SOPHiA GENETICS SA ranks as a small-cap company within healthcare. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Market Cap
$354.6M
Beta
1.01
P/E (TTM)
—
P/E (Fwd)
-8.82
EPS (TTM)
$-1.18
EPS (Fwd)
$-0.56
ROE
-123.3%
ROA
-29.7%
Cash
$65.4M
Total Debt
$62.4M
Free CF
-$24.6M
52W Change
64.7%
Annual Financials
Cash vs Debt
With $65.4M in cash and $62.4M in debt, SOPH maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$24.6M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -123.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $40.5M (2021) to $77.3M (2025), reflecting a 91% increase over the period.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing SOPH's risk profile alongside its fundamentals and technical indicators provides a more complete picture.